Management of pediatric dialysis and kidney transplant patients after natural or man-made disasters

  • Lale Sever
  • Gülseren Pehlivan
  • Nur Canpolat
  • Seha Saygılı
  • Ayşe Ağbaş
  • Ebru Demirgan
  • Jun Oh
  • Elena Levtchenko
  • Dymtro D Ivanov
  • Rukshana Shroff

Abstract

Pediatric patients on kidney replacement therapy (KRT) are among the most vulnerable during large-scale disasters, either natural or man-made. Hemodialysis (HD) treatments may be impossible because of structural damage and/or shortage of medical supplies, clean water, electricity, and healthcare professionals. Lack of peritoneal dialysis (PD) solutions and increased risk of infectious/non-infectious complications may make PD therapy challenging. Non-availability of immunosuppressants and increased risk of infections may result in graft loss and deaths of kidney transplant recipients. Measures to mitigate these risks must be considered before, during, and after the disaster including training of staff and patients/caregivers to cope with medical and logistic problems. Soon after a disaster, if the possibility of performing HD or PD is uncertain, patients should be directed to other centers, or the duration and/or number of HD sessions or the PD prescription adapted. In kidney transplant recipients, switching among immunosuppressants should be considered in case of non-availability of the medications. Post-disaster interventions target treating neglected physical and mental problems and also improving social challenges. All problems experienced by pediatric KRT patients living in the affected area are applicable to displaced patients who may also face extra risks during their travel and also at their destination. The need for additional local, national, and international help and support of non-governmental organizations must be anticipated and sought in a timely manner.

Bibliografische Daten

OriginalspracheEnglisch
ISSN0931-041X
DOIs
StatusVeröffentlicht - 02.2023

Anmerkungen des Dekanats

© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.

PubMed 36194369